Piver 1974.
Methods | Randomized, double blind, placebo controlled | |
Participants | n=41 FIGO stage IIB or IIIB ca cx | |
Interventions | RT ‐ 40 ‐ 50Gy EBRT in 2Gy fractions followed by ICR & VR. Point A dose = 85Gy. HU ‐ 80mg/kg 3 x wk over 12 wks | |
Outcomes | Acute chemotherapy toxicity NED rate | |
Notes | Trial stopped as high proportion of 3b pts had PA node mets | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Allocation concealment? | Low risk | A ‐ Adequate |